[1]潘晶晶,吴海霞,曾 骥,等.温阳化痰方治疗老年缺血性脑卒中疗效及相关机制[J].陕西中医,2025,46(3):345-349.[doi:DOI:10.3969/j.issn.1000-7369.2025.03.012]
 PAN Jingjing,WU Haixia,ZENG Ji,et al.Effect and related mechanisms of Wenyang Huatan formula on elderly ischemic stroke[J].,2025,46(3):345-349.[doi:DOI:10.3969/j.issn.1000-7369.2025.03.012]
点击复制

温阳化痰方治疗老年缺血性脑卒中疗效及相关机制
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
46
期数:
2025年3期
页码:
345-349
栏目:
临床研究
出版日期:
2025-03-05

文章信息/Info

Title:
Effect and related mechanisms of Wenyang Huatan formula on elderly ischemic stroke
作者:
潘晶晶吴海霞曾 骥李小山宋振华
(中南大学湘雅医学院附属海口医院,海南 海口 570208)
Author(s):
PAN JingjingWU HaixiaZENG JiLI XiaoshanSONG Zhenhua
(Haikou Affiliated Hospital of Central South University Xiangya School of Medicine,Haikou 570208,China)
关键词:
缺血性脑卒中 温阳化痰方 血管性痴呆 音猬因子 长链非编码 RNA小核仁RNA宿主基因8 神经调节蛋白1 早期生长反应因子-1
Keywords:
Ischemic stroke Wenyang Huatan formula Vascular dementia Sound hedgehog factor LncRNA SNHG8 NRG1 Egr-1
分类号:
R 255.2
DOI:
DOI:10.3969/j.issn.1000-7369.2025.03.012
文献标志码:
A
摘要:
目的:探讨温阳化痰方治疗老年缺血性脑卒中(IS)临床疗效及其治疗机制。方法:选择老年IS患者110例,按照随机数字表法分为观察组、对照组,每组55例。对照组予以规范的西医治疗,观察组在此基础上口服中药温阳化痰方。比较两组治疗前后中医证候评分、美国国立卫生研究院卒中量表(NIHSS)评分、Berg平衡量表(BBS)评分、Sheikh控制量表(SCS)评分以及患者血清多巴胺(DA)、乙酰胆碱(ACh)、神经调节蛋白1(NRG1)、早期生长反应因子-1(Egr-1)、音猬因子(SHH)水平、长链非编码 RNA小核仁RNA宿主基因8(LncRNA SNHG8)相对表达量。比较两组治疗效果。结果:治疗后,观察组各项中医证候评分、NIHSS评分低于对照组,BBS、SCS评分高于对照组,差异有统计学意义(均P<0.05)。治疗后,观察组血清DA、ACh、NRG1、SHH水平及LncRNA SNHG8相对表达量高于对照组,血清Egr-1水平低于对照组,差异有统计学意义(均P<0.05)。治疗总有效率高于对照组(P<0.05)。结论:温阳化痰方治疗老年IS效果较好,其机制可能与调节SHH、LncRNA SNHG8有关。
Abstract:
Objective:To explore clinical efficacy of Wenyang Huatan formula in treatment of elderly ischemic stroke(IS)and analyze its treatment mechanism preliminarily.Methods:110 elderly IS patients were selected and divided into observation group and control group according to digital random table method, with 55 cases in each group.The control group received standardized western medicine treatment, while the observation group took Wenyang Huatan formula orally on the basis of the control group.The traditional Chinese medicine syndrome scores,NIHSS scores,BBS scores and SCS scores before and after treatment between the two groups were compared,serum dopamine(DA), acetylcholine(ACh), neuroregulatory protein 1(NRG1),Egr-1,levels of sound hedgehog factor(SHH)and relative expression level of long chain non coding RNA small nucleolar RNA host gene 8(LncRNA SNHG8)were compared.The total efficacy of the two groups were compared.Results:After treatment,scores of various traditional Chinese medicine symptoms and NIHSS of the observation group were lower than those in the control group, while the scores of BBS and SCS were higher than those in the control group(all P<0.05).The levels of serum DA,ACh,NRG1,SHH and relative expression of LncRNA SNHG8 of the observation group were higher than those in the control group, while the levels of serum Egr-1 were lower than those of the control group(all P<0.05).The total effective rate of treatment was higher than that of the control group(P<0.05).Conclusion:Wenyang Huatan has significant therapeutic effect on elderly IS.Its mechanism may be related to regulation of SHH and LncRNA SNHG8.

参考文献/References:

[1] 孙玉婷,张文,蒲玉婷,等.基于RhoA/ROCK信号通路探讨中药干预缺血性脑卒中的研究进展[J].上海中医药杂志,2024,58(11):97-100.
[2] 李斌,王高临,韩桂浩,等.Solitaire AB支架机械取栓联合动脉溶栓治疗急性缺血性脑卒中疗效观察[J].陕西医学杂志,2024,53(6):806-809,813.
[3] 《中国脑卒中防治报告》编写组.《中国脑卒中防治报告2020》概要[J].中国脑血管病杂志,2022,19(2):136-144.
[4] MA Q F,LI R,WANG J,et al.Temporal trend and attributable risk factors of stroke burden in China 1990-2019:An analysis for the global burden of disease study 2019[J].The Lancet Public Health,2021,6(12):e897-e906.
[5] 刘洋,王妍,滕玉欢,等.血清NSE、Hcy及GAP-43水平与老年缺血性脑卒中的相关性[J].中国老年学杂志,2023,43(20):4885-4887.
[6] NIE X, LIU L.Endovascular treatment with or without intravenous alteplase for acute ischaemic stroke due to basilar artery occlusion[J].Stroke Vasc Neurol,2022, 7(3):190-199.
[7] 龚翠兰,马强,杨仁义,等.基于生物信息学和动物实验筛选缺血性脑卒中血管新生关键基因与活血荣络方的干预作用[J].中成药,2024,46(11):3834-3842.
[8] 刘晶,古联,杨怡冰,等.基于表观遗传学探讨中医药治疗缺血性脑卒中的研究进展[J].中华中医药杂志,2023,38(8):3715-3718.
[9] 寿雅琨,刘芳,周胜强,等.国医大师刘祖贻运用温阳活血法治疗中风后遗症经验[J].湖南中医药大学学报,2019,39(10):1179-1182.
[10] 谭春凤,郑全成,徐琼,等.补阳还五汤配合温阳针灸法治疗老年缺血性脑卒中恢复期气虚血瘀证的疗效观察[J].中华中医药学刊,2023,41(7):230-234.
[11] 张敌,王彦华,陈昺伃.脑卒中半身不遂中医病机探析[J].陕西中医,2024,45(7):947-950.
[12] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):666-682.
[13] 中国中西医结合学会神经科专业委员会.中国脑梗死中西医结合诊治指南(2017)[J].中国中西医结合杂志,2018,38(2):136-144.
[14] 国家中医药管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:99-104.
[15] 陈培峰,张民,曲培向.基于NIHSS评分、血液流变学及内皮功能评价扎冲十三味丸治疗脑梗死后偏瘫的疗效[J].吉林中医药,2023,43(2):186-189.
[16] ROTH G A,JOHNSON C O,NGUYEN G,et al.Methods for estimating the global burden of cerebrovascular diseases[J].Neuroepidemiology,2015,45(3):146-151.
[17] WANG W,JIANG B,SUN H,et al.NESS-China investigators prevalence incidence and mortality of stroke in China:Results from a nationwide population-based survey of 480687 adults[J].Circulation,2017,135(8):759-771.
[18] 刘庆杰,杨璨宇,查文文.阿司匹林抵抗和脂蛋白相关磷脂酶A2与复发性缺血性脑卒中的相关性分析[J].中国实用神经疾病杂志,2025,28(1):83-87.
[19] 陈怡然,陈海生,高敏,等.芪蛭通络汤对痰瘀阻络证脑卒中患者的临床疗效[J].中成药,2024,46(12):4232-4235.
[20] 孙洋子,伍贞宇,游咏,等.基于Solitaire AB支架的血管内治疗大动脉闭塞急性轻型缺血性脑卒中患者的疗效观察[J].中国实用神经疾病杂志,2025,28(1):53-57.
[21] 朱建,王缘,桑穆惠,等.化痰通络方联合依达拉奉右莰醇对缺血性脑卒中风痰阻络证患者血浆ICAM-1、脑钠肽表达的影响[J].中医药学报,2024,52(12):84-88.
[22] 周辉,冯兵,刘旭日,等.基于机器学习的静脉溶栓时间窗外急性缺血性脑卒中患者短期预后模型建立与验证[J].广西科学,2024,31(4):781-787.
[23] 施婷婷,周焱萍.滋肾通髓方结合早期溶栓对急性脑卒中患者脑神经递质、血管储备功能及脂质过氧化的影响[J].中医学报,2023,38(10):2228-2234.
[24] LARSEN K,JAEGER H S,TVEIT L H,et al.Ultraearly thrombolysis by an anesthesiologist in a mobile stroke unit:A prospective controlled intervention study[J].Eur J Neurol,2021,28(8):2488-2496.
[25] VRILLON A,MOUTON-LIGER F,MARTINET M,et al.Plasma neuregulin 1 as a synaptic biomarkerin Alzheimer's disease:A discovery cohort study[J].Alzheimers Res Ther,2022,14(1):71.
[26] 宋丹,白洪超,陆平.补阳还五汤加味联合依帕司他对气虚血瘀型糖尿病周围神经病变疗效及炎症因子、NRG1、Irisin的影响分析[J].四川中医,2024,42(2):141-145.
[27] 曾伟兰,汪艳.早期生长反应蛋白1参与肝病发生主要病理机制研究进展[J].中国药理学与毒理学杂志,2020,34(9):702-712.
[28] RAJARAMAN B,RAMADAS N,KRISHNASAMY S,et al.Hyperglycaemia cause vascular inflammation through advanced glycation end products/early growth response-1 axis in gestational diabetes mellitus [J].Mol Cell Biochem,2019,456(1):179-190.
[29] 涂艳,王丽平.老年缺血性脑卒中患者血清Egr-1、Neuregulin1表达水平对血管性痴呆的预测效能[J].国际检验医学杂志,2023,44(19):2385-2389.
[30] 张珊珊,季一飞,张翼,等.音猬因子、小而密低密度脂蛋白胆固醇、25-羟维生素D、转铁蛋白水平与老年急性脑梗死患者病情严重程度及预后的关系研究[J].实用医院临床杂志,2020,17(1):33-36.
[31] HUANG D Z, CAO Y B, ZU T T, et al.Interference with long noncoding RNA SNHG3 alleviates cerebral ischemia-reperfusion injury by inhibiting microglial activation[J].Journal of Leukocyte Biology, 2022, 111(4):759-769.
[32] TIAN J A, LIU Y H, WANG Z Q, et al.LncRNA SNHG8 attenuates microglial inflammation response and blood-brain barrier damage in ischemic stroke through regulating miR-425-5p mediated SIRT1/NF-κB signaling[J].Journal of Biochemical and Molecular Toxicology, 2021, 35(5):e22724.

相似文献/References:

[1]耿银龙,张伟萍,任梦诗.温阳复元方对缺血性脑卒中患者运动功能及生存质量影响研究*[J].陕西中医,2020,(2):172.
 GENG Yinlong,ZHANG Weiping,REN Mengshi..Effect of Wenyang Fuyuan decoction on motor function and quality of life in patients with ischemic stroke[J].,2020,(3):172.
[2]杨 倩,屈 云,王凤英△.脊柱推拿联合康复治疗对缺血性脑卒中患者手功能的影响*[J].陕西中医,2020,(11):1580.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.017]
 YANG Qian,QU Yun,WANG Fengying..Effect of spinal massage combined with routine rehabilitation therapy on recovery from hand dysfunction after ischemic stroke[J].,2020,(3):1580.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.017]
[3]徐亚辉,才丽娜,贺大权,等.活血复健汤治疗脑卒中疗效及对患者神经功能与血清相关指标的影响*[J].陕西中医,2020,(11):1615.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.026]
 XU Yahui,CAI Li'na,HE Daquan,et al.The effect of Huoxue Fujian decoction on cerebral apoplexy and its related indexes of nerve function and serum[J].,2020,(3):1615.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.026]
[4]张锡萍,张斐雪,郑书林,等.血栓通联合吡拉西坦对缺血性脑卒中患者中医证候评分、神经功能及血清NPY、Hcy水平的影响[J].陕西中医,2021,(3):326.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.014]
 ZHANG Xiping,ZHANG Feixue,ZHENG Shulin,et al.Influence of Xueshuantong combined with piracetam on TCM syndrome score neurological function and serum NPY and Hcy in patients with cerebral ischemic stroke[J].,2021,(3):326.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.014]
[5]吕鸿燕,严兴亚,李 凤,等.缺血性脑卒中患者中医证型与Crouse积分、血清同型半胱氨酸、凝血功能相关性研究[J].陕西中医,2021,(7):879.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.017]
 LYU Hongyan,YAN Xingya,LI Feng,et al.Correlation between TCM syndromes and Crouse score,serum Hcy,coagulation function in patients with ischemic stroke[J].,2021,(3):879.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.017]
[6]陈雨菡,马善波,杨 倩,等.黄芪-丹参药对治疗缺血性脑卒中研究进展[J].陕西中医,2021,(8):1142.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.038]
 CHEN Yuhan,MA Shanbo,YANG Qian,et al.Therapeutic effect of Astragali-Salvia miltiorrhiza for ischemic stroke[J].,2021,(3):1142.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.038]
[7]倪广晓,段春巧,周宏斌,等.基于BDNF-Trk B信号通路探讨和血生络方对脑缺血大鼠认知功能的影响及机制研究[J].陕西中医,2021,(11):1481.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.001]
 NI Guangxiao,DUAN Chunqiao,ZHOU Hongbin,et al.Investigated effect of Hexue Shengluo decoction on cognitive function in MCAO rats and mechanism based on BDNF-Trk B signaling pathway[J].,2021,(3):1481.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.001]
[8]王少琴,刘丽彬.子午流注纳子法结合温通针法对缺血性脑卒中患者下肢肢体功能康复及脑血流水平的影响[J].陕西中医,2022,(4):523.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.029]
 WANG Shaoqin,LIU Libin.Effects of Ziwu Liuzhu Nazi method combined with Wentong acupuncture method on lower limb function and cerebral blood flow in patients with ischemic stroke[J].,2022,(3):523.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.029]
[9]郑 勇,程 贝,陈亦辉,等.星蒌承气汤联合丁苯酞治疗缺血性脑卒中疗效及对患者氧化应激、血液流变学的影响[J].陕西中医,2023,(2):191.[doi:DOI:10.3969/j.issn.1000-7369.2023.02.012]
 ZHENG Yong,CHENG Bei,CHEN Yihui,et al.Effect of Xinglou Chengqi decoction combined with butylphthalide on oxidative stress and hemorheology in patients with ischemic stroke[J].,2023,(3):191.[doi:DOI:10.3969/j.issn.1000-7369.2023.02.012]
[10]王小亮,李振东,邱航健,等.耳穴贴压对脑缺血损伤大鼠干预机制研究[J].陕西中医,2023,(7):849.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.005]
 WANG Xiaoliang,LI Zhendong,QIU Hangjian,et al.Study on intervention mechanism of auricular acupoint pressing on rats with ischemic stroke[J].,2023,(3):849.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.005]

备注/Memo

备注/Memo:
[基金项目]海南省临床医学中心建设项目(0202067); 海南省卫生健康行业科研项目(21A200048)
更新日期/Last Update: 2025-03-10